|
市場調査レポート
商品コード
1519774
外科手術用画像市場レポート:技術タイプ、モダリティタイプ、用途、エンドユーザー、地域別、2024年~2032年Surgical Imaging Market Report by Technology Type (Image Intensifier, Flat Panel Detector ), Modality Type, Application, End User, and Region 2024-2032 |
||||||
カスタマイズ可能
|
外科手術用画像市場レポート:技術タイプ、モダリティタイプ、用途、エンドユーザー、地域別、2024年~2032年 |
出版日: 2024年07月01日
発行: IMARC
ページ情報: 英文 135 Pages
納期: 2~3営業日
|
世界の外科手術用画像の市場規模は2023年に65億米ドルに達しました。今後、IMARC Groupは、2024年から2032年にかけての成長率(CAGR)は5.3%を示し、2032年には104億米ドルに達すると予測しています。市場を牽引しているのは、外科手術件数の増加、外科的介入を必要とする慢性疾患の拡大、高度な画像技術を備えたハイブリッド手術室の普及です。
主な市場促進要因:慢性疾患の頻度増加、高度な診断や外科的介入の必要性、3DイメージングやポータブルCアーム装置を備えたイメージングシステムの技術進歩が、低侵襲手術の需要拡大に対応しています。
主要市場動向:手術用画像システムにおける人工知能(AI)と機械学習(ML)の融合により、リアルタイムの画像解析が簡素化され、外科医が十分な情報に基づいた決断を下せるようになります。外科手術用画像の市場の概要によると、高度な画像処理装置を備えたハイブリッド手術室の採用により、複雑な手術を高い精度と安全性で実施できるようになります。
地理的動向:北米の成長は、確立されたヘルスケアインフラ、高い医療費、先端技術の急速な導入によるものです。また、アジア太平洋地域は、特に中国やインドなどの国々で、集団医療投資、医療ツーリズムの台頭、医療施設へのアクセス強化により急成長を遂げています。
競合情勢:外科手術用画像処理企業には、Canon Medical Systems Corporation、General Electric Company、Geonoray Co.Ltd.、Hologic Inc.、Koninklijke Philips N.V.、Medtronic Plc、Primax International Srl、Prognosys Medical Systems Private Limited、島津製作所、Siemens Aktiengesellschaft、Trivitron Healthcare Pvt. Ltd.、Whale Imaging Inc.、Ziehm Imaging GmbH(Aton GmbH)などです。
課題と機会:高度な画像処理技術と厳しい規制要件に関連したコスト高が、低所得地方での利用を制限し、課題となっています。外科手術用画像の市場によると、最近のビジネスチャンスは、外科手術用画像処理システムの用途が従来の分野を超えてスポーツ医学やリウマチ学などの分野に拡大することにあります。
外科手術の増加
外科手術は世界的に外科手術用画像の市場の成長にとって極めて重要な起爆剤となっています。医療技術の進歩やヘルスケアサービスへのアクセスの増加に伴い、さまざまな病状に対処するために外科的介入を受ける人が増えています。例えば、2023-24年度の手術件数は、2022-23年度に記録した前回を6,000件近く上回っています。人工股関節置換術と人工膝関節置換術は、カナダ・サスカチュワン州で最も件数の多い手術のひとつです。具体的には、人工股関節置換術と人工膝関節置換術の年間件数は、前年のほぼ6,300件から2023-2024年にはほぼ7,100件に増加しました。今年度2023年4月1日から2024年3月31日に実施された人工関節置換術の規模は、2019-20年に記録されたCOVID-19パンデミック前の年間規模を50%上回った。2023年4月1日と2024年3月31日には、95,700件の手術が効率的に監督され、過去に記録された中で最も過剰な年間手術規模を記録しました。また、2024-2025年の予算では、手術能力の向上と待ち時間の短縮のために228万米ドルの追加投資が行われています。したがって、ヘルスケア組織の拡大が外科手術用画像の市場の成長率上昇に寄与しています。
慢性疾患の流行
慢性疾患の蔓延は外科的介入の必要性を著しく高める。心血管疾患、がん、神経疾患などの治療には、診断、治療、症状管理のための外科的処置が必要です。ライフスタイルの変化、人口の高齢化、環境要因が疾病負担に寄与するにつれ、慢性疾患の発生率は上昇を続けています。例えば、2024年1月の英国心臓財団(BRITISH HEART FOUNDATION)によると、英国では約760万人が心臓・循環器疾患に罹患しています。この数は、人口の高齢化と心臓・循環器疾患後の生存率の向上により、増加する傾向にあります。また、男性約400万人、女性約360万人が心臓・循環器系疾患に罹患していることも明らかになっています。英国の人口の半数以上が、生涯のどこかで心臓や循環器系の病気にかかると予測されています。注目すべきことに、心臓・循環器疾患は、英国における年間死亡者数の約27%を占めており、17万人以上、1日当たり約480人、3分に1人が死亡している計算になります。さらに、心臓・循環器系疾患は、英国で75歳未満の年間49,000人近くの命を奪っています。これに加え、心血管疾患(CVD)患者の増加が予測されるため、外科手術用画像の市場の需要は増加し続けると思われます。
ハイブリッド手術室の採用
ハイブリッド手術室の急速な導入は、手術環境に高度な画像技術を統合することで、外科診療におけるパラダイムシフトを象徴しています。さらに、ハイブリッド手術室は、従来の手術機器と血管造影装置やMRI装置などの最先端の画像システムを組み合わせたものです。これにより、解剖学的構造や手術の進行状況をリアルタイムで視覚化でき、手技の正確性と患者の安全性が高まる。低侵襲手技や複雑な介入に対する需要の高まりが、ハイブリッド手術室施設の世界の拡大を後押ししています。一例を挙げると、2023年の世界のハイブリッド手術室市場規模は11億9,460万米ドルでした。今後、IMARC Groupは、ハイブリッド手術室市場が2032年までに27億5,090万米ドルを達成し、2024年から2032年までのCAGRが9.42%になると予測しています。ハイブリッド手術室市場は、技術の進歩と高度な外科的介入に対する需要の増加により成長を続けており、外科手術用画像の市場の見通しは良好です。
The global surgical imaging market size reached US$ 6.5 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 10.4 Billion by 2032, exhibiting a growth rate (CAGR) of 5.3% during 2024-2032. The market is driven by the increasing number of surgical procedures, the expanding number of chronic ailments requiring surgical interventions, and the widespread adoption of hybrid operating rooms equipped with advanced imaging technologies are propelling the market growth.
Major Market Drivers: The growing frequency of chronic diseases, the need for advanced diagnostic, surgical interventions, and technological advancements in imaging systems with 3D imaging and portable C-arm devices accommodate to the growing demand for minimally invasive surgeries.
Key Market Trends: The union of artificial intelligence (AI) and machine learning (ML) in surgical imaging systems simplifies real-time imaging analytics, which supports surgeons in making informed decisions through procedures. As per the surgical imaging market overview, the adoption of hybrid operating rooms equipped with advanced imaging devices allows complex surgeries to be performed with high precision and safety.
Geographical Trends: The growth of North America is due to established healthcare infrastructure, elevated healthcare expenditure, and rapid adoption of advanced technologies. Also, the Asia-Pacific region is perceiving rapid growth owing to collective healthcare investments, emerging medical tourism, and intensifying access to healthcare facilities, particularly in countries such as China and India.
Competitive Landscape: Some of the surgical imaging companies include Canon Medical Systems Corporation, General Electric Company, Geonoray Co. Ltd., Hologic Inc., Koninklijke Philips N.V., Medtronic Plc, Primax International Srl, Prognosys Medical Systems Private Limited, Shimadzu Corporation, Siemens Aktiengesellschaft, Trivitron Healthcare Pvt. Ltd, Whale Imaging Inc., and Ziehm Imaging GmbH (Aton GmbH), among many others.
Challenges and Opportunities: The elevated costs linked with advanced imaging technologies and stringent regulatory requirements pose challenges to market development limiting availability in lower-income provinces. As per the surgical imaging market recent opportunities lie in the expansion of applications for surgical imaging systems beyond traditional fields into areas like sports medicine and rheumatology.
Increasing Surgical Procedures
The surgical procedures globally serve as a pivotal catalyst for the growth of the surgical imaging market. With advancements in medical technology and increasing access to healthcare services, more individuals are undergoing surgical interventions to address various medical conditions. For instance, in the fiscal year 2023-24, the number of surgeries performed exceeded the previous record set in 2022-23 by almost 6,000. There is a distinguished focus on hip and knee replacement surgeries, which rank among the highest-volume procedures in Saskatchewan, Canada. Explicitly, the annual volumes for hip and knee replacements rose from nearly 6,300 in the preceding year to almost 7,100 in 2023-2024. The size of joint substitute procedures conducted during this fiscal year April 1, 2023, to March 31, 2024, was 50% higher than the yearly size before the COVID-19 pandemic, recorded in 2019-20. On April 1, 2023, and March 31, 2024, 95,700 surgeries were efficiently supervised marking the most excessive annual surgical size ever documented. Also, the budget for 2024-2025 offers an additional investment of $2.28 million for increasing surgical capacities and diminishing wait times. Hence, the expanding healthcare organization contributes to the rise in surgical imaging market growth.
Prevalence of Chronic Diseases
The prevalence of chronic diseases significantly drives the need for surgical interventions. Conditions such as cardiovascular diseases, cancer, and neurological disorders require surgical procedures for diagnosis, treatment, or symptom management. As lifestyles change, populations age and environmental factors contribute to disease burden, the incidence of chronic illnesses continues to rise. For instance, as per the BRITISH HEART FOUNDATION in January 2024, in the UK, approximately 7.6 million individuals are afflicted with heart and circulatory diseases. This number is poised to increase due to an aging population and better survival rates following heart and circulatory incidents. It also reveals about 4 million men and 3.6 million women are affected by heart and circulatory diseases. It is projected that over half of the UK, population will experience a heart or circulatory disease at some point in their lives. Notably, heart and circulatory diseases are responsible for about 27% of all UK deaths annually, translating to more than 170,000 deaths or roughly 480 daily, amounting to one death every 3 minutes. Furthermore, heart and circulatory diseases claim nearly 49,000 lives under 75 years old annually in the UK. Besides this, the projected increase in cardiovascular disease (CVD) cases will continue to increase surgical imaging market demand.
Adoption of Hybrid Operating Rooms
The rapid adoption of hybrid operating rooms represents a paradigm shift in surgical practice, integrating advanced imaging technologies into surgical environments. Additonally, hybrid operating rooms combine traditional surgical equipment with state-of-the-art imaging systems such as angiography and MRI machines. It enables real-time visualization of anatomical structures and surgical progress, enhancing procedural accuracy and patient safety. The growing demand for minimally invasive procedures and complex interventions drives the expansion of hybrid operating room facilities worldwide. To state an instance, in 2023, the size of the global hybrid operating room market amounted to US$ 1,194.6 million. Moving ahead, IMARC Group anticipates the hybrid operating room market to achieve US$ 2,750.9 million by 2032, showcasing a compound annual growth rate (CAGR) of 9.42% from 2024 to 2032. As the hybrid operating room market continues to grow due to technological advancements and increasing demand for sophisticated surgical interventions it is creating a favorable surgical imaging market outlook.
IMARC Group provides an analysis of the key trends in each segment of the market, along with forecasts at the global, regional, and country levels for 2024-2032. Our report has categorized the market based on technology type, modality type, application, and end user.
Image Intensifier
Flat Panel Detector (FPD)
Flat panel detector (FPD) accounts for the majority of the market share
The report has provided a detailed breakup and analysis of the market based on the technology type. This includes an image intensifier, and flat panel detector (FPD). According to the report, flat panel detector (FPD) represented the largest segment.
Flat panel detectors (FPD) are highly favored in surgical imaging due to their superior image quality, lower radiation exposure, and greater durability compared to other imaging technologies. These detectors are extensively used in various surgical procedures, including orthopedic, cardiovascular, and neuro surgeries, driving their high adoption rate. For instance, on 6 July 2023, Shimadzu Medical Systems USA, a division of Shimadzu Corporation introduced the new V series Glass-Free Flat Panel Detectors (FPD), now integrated with general radiography platforms. These innovative glass-free FPD detectors feature a 99-micron pixel pitch for capturing highly detailed X-ray images. Additionally, their lightweight construction eases the workload on radiology technologists and increases durability against drops. It is available in three dimensions such as 17"x17", 14"x17", and 10"x12" that are compatible with RADspeed Pro style edition V series and MobileDaRt Evolution MX8 V type systems. Thus, FPD continues to dominate the market, due to the ongoing advancements and increasing demand for minimally invasive surgeries.
Mobile C-Arms
Mini C-Arms
Others
A detailed breakup and analysis of the market based on the modality type have also been provided in the report. This includes mobile c-arms, mini c-arms, and others.
Mobile C-Arms are versatile imaging devices used extensively in operating rooms for a variety of diagnostic and interventional procedures. Their design allows for greater flexibility and mobility, making them ideal for surgeries requiring real-time imaging feedback such as orthopedics, cardiology, and vascular surgery. These systems provide high-resolution X-ray images, enabling precise placement of surgical instruments and implants. For instance, on 13 September 2023, Philips, a prominent leader in health technology, expanded its mobile C-arm lineup with the introduction of the Zenition 30, enhancing the capabilities of surgical teams by allowing surgeons more customization and autonomy in their use. It enhances the operational flexibility and customization for surgeons in C-arm usage and image capture, reducing the need for extensive technician assistance across various minimally invasive surgeries. The system is equipped with advanced imaging algorithms that ensure superior image quality and efficient dosage use. Thus, the demand for mobile C-Arms is increasing owing to their capability to facilitate quicker, more accurate surgical outcomes which is generating a surgical imaging market revenue.
Besides this, Mini C-Arms are compact, portable imaging devices specifically suited for extremity imaging, particularly in orthopedic and podiatric surgeries. These smaller versions of the traditional C-Arm are preferred for outpatient settings and smaller clinics due to their reduced size and ease of use. They are particularly valuable in sports medicine, pediatric applications, and intraoperative imaging where space and quick setup are crucial. Apart from this, mini C-Arms are also cost-effective, which makes them an attractive option for facilities with limited budgets or those that require a device dedicated to specific types of surgical procedures.
Neurosurgery
Orthopedic and Trauma Surgery
Cardiovascular
General Surgery
Others
Orthopedic and trauma surgery represents the leading market segment
The report has provided a detailed breakup and analysis of the market based on the application. This includes neurosurgery, orthopedic and trauma surgery, cardiovascular, general surgery, and others. According to the report, orthopedic and trauma surgery represented the largest segment.
Orthopedic and trauma surgery is leading the market due to the increasing incidence of bone-related injuries and the rising demand for precise real-time imaging during complex orthopedic surgeries. Surgical imaging devices such as mobile C-arms have become essential in ensuring high accuracy and better outcomes in these procedures. The technological advancements in imaging technologies that offer enhanced image clarity and reduced exposure to radiation are further making them indispensable in today's orthopedic and trauma surgical practices, thus creating the surgical imaging market recent opportunities across the globe.
Hospitals
Surgery Centers and Clinics
Hospitals exhibit a clear dominance in the market
A detailed breakup and analysis of the market based on the end user have also been provided in the report. This includes hospitals, surgery centers and clinics. According to the report, hospitals accounted for the largest market share.
Hospitals are driven by the high volume of complex surgeries, which necessitate advanced imaging technologies for accurate diagnostics and procedural guidance. It also has greater financial capabilities to invest in sophisticated surgical imaging systems compared to smaller clinics or diagnostic centers. Moreover, the push toward minimally invasive procedures, which require precise imaging for successful outcomes, further boosts the demand for high-end surgical imaging equipment within hospital settings. This trend is expected to continue as hospitals expand their technological capabilities to enhance surgical outcomes and patient care. Thus, in July 2021, the Government of Ontario allocated as much as $324 million to support Ontario's hospitals and community health sectors. This investment was designed to increase the capacity for more surgeries, MRI and CT scans, and other medical procedures, including during evenings and weekends. It is part of a broader, detailed plan aimed at improving surgical recovery and ensuring patients receive the necessary care. It allowed up to 67,000 extra surgeries and procedures. It provided up to 135,000 additional hours of diagnostic imaging which reduced wait times for medical procedures, enhanced access to healthcare services, and fulfilled the government's pledge to eliminate healthcare services in hallways.
North America
United States
Canada
Asia-Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
North America leads the market, accounting for the largest surgical imaging market share
The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America represents the largest regional market for surgical imaging.
The market in North America is leading due to advanced healthcare infrastructure, high adoption rates of cutting-edge medical technologies, and significant investments in research and development thus creating a positive surgical imaging market forecast. The region benefits from a robust regulatory framework that supports rapid approvals of innovative imaging technologies, facilitating their integration into surgical practices. For instance, in January 2024, Shimadzu Medical Systems USA, a branch of Shimadzu Corporation, achieved HCAI Special Seismic Certification preapproval for its FLUOROspeed X1 model. This certification confirms the system's ability to withstand earthquakes, enabling the deployment of this advanced patient-side conventional RF table system in California's healthcare settings. The FLUOROspeed X1, featuring patient-side table controls for easier operation, includes a 17"x17" dynamic digital X-ray detector (FPD) embedded in the table bucky, suitable for fluoroscopy and radiographic examinations. Its 31.5-inch gap between the tabletop and deck makes it an excellent digital RF system for imaging patients in wheelchairs and fits well in smaller spaces.
The market research report has also provided a comprehensive analysis of the competitive landscape in the market. Detailed profiles of all major companies have also been provided. Some of the major market players in the surgical imaging industry include Canon Medical Systems Corporation, General Electric Company, Geonoray Co. Ltd., Hologic Inc., Koninklijke Philips N.V., Medtronic Plc, Primax International Srl, Prognosys Medical Systems Private Limited, Shimadzu Corporation, Siemens Aktiengesellschaft, Trivitron Healthcare Pvt. Ltd, Whale Imaging Inc., and Ziehm Imaging GmbH (Aton GmbH).
(Please note that this is only a partial list of the key players, and the complete list is provided in the report.)
At present, the surgical imaging market recent developments by key players include innovation and expansion of product portfolios to meet the diverse needs of modern healthcare. These companies focus on developing advanced imaging technologies that offer clearer, more precise visuals to support complex surgical procedures. Many are also forging strategic partnerships and acquisitions to enhance their market reach and technological capabilities. Additionally, they invest heavily in research and development to introduce AI-driven and minimally invasive imaging solutions, aimed at improving patient outcomes and operational efficiency in hospitals and surgical centers. This strategic focus ensures their strong position in the competitive landscape. On 28 August 2022, Siemens Healthineers disclosed that the ARTIS icono ceiling, a ceiling-mounted angiography system, has received clearance from the Food and Drug Administration (FDA). This system is tailored to accommodate a broad spectrum of routine and advanced procedures in interventional radiology (IR) and cardiology. Moreover, its notable mechanical flexibility renders it applicable for various surgical interventions as well.
On 21 March 2024, Siemens Healthineers received approval from the Food and Drug Administration (FDA) for its CIARTIC Move, a mobile C-arm equipped with autonomous driving features. This system enhances the efficiency and standardization of 2D fluoroscopic imaging and 3D cone-beam CT scans for surgical teams in hospital and outpatient settings. By automating workflows, the CIARTIC Move streamlines the imaging process during surgeries, thereby improving consistency and reducing operation times. It is specifically designed for use in orthopedic, trauma, and spine surgeries and is adaptable for use in thoracic, vascular, cardiovascular, general surgeries, urology, and interventional pulmonology.
On 28 February 2024, Royal Philips, a prominent health technology company, introduced the Philips Image Guided Therapy Mobile C-arm System 9000 Zenition 90 Motorized. This new mobile C-arm is engineered to support surgeons in providing top-tier care to an increased number of patients. The system, enhanced to handle complex vascular conditions and various clinical operations such as cardiac procedures, pain management, and urology, is set to be commercially available starting in the second quarter of 2024. The automated processes enhance the flexibility and autonomy of surgeons, and intuitive motorization delivers enhanced control, while high-power (25 kW) capabilities support exceptional image quality, meeting the demands of complex vascular requirements and various clinical procedures.